Synthesis and biological activity of fluoro-substituted pyrrolo[2,3-d]pyrimidines:: The development of potential positron emission tomography imaging agents for the corticotropin-releasing hormone type 1 receptor

被引:21
作者
Hsin, LW
Webster, EL
Chrousos, GP
Gold, PW
Eckelman, WC
Contoreggi, C
Rice, KC [1 ]
机构
[1] NIDDK, Med Chem Lab, NIH, Bethesda, MD 20892 USA
[2] NIMH, Clin Neuroendocrinol Branch, Ctr Clin, NIH, Bethesda, MD 20892 USA
[3] NICHD, Pediat Endocrinol Sect, PREB, Clin Ctr,NIH, Bethesda, MD 20892 USA
[4] NIH, Dept Nucl Med, Ctr Clin, Bethesda, MD 20892 USA
[5] NIDA, Brain Imaging Unit, Baltimore, MD 21224 USA
关键词
D O I
10.1016/S0960-894X(00)00071-8
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of fluoro-substituted 4-(dialkylamino)pyrrolo[2,3-n]pyrimidines was synthesized and their binding affinity for corticotropin-releasing hormone type 1 receptor (CRHR1) was investigated. Compounds 11a and 11b possessed very high CRHR1 affinity (K-i = 3.5, 0.91 nM, respectively). They are promising candidates for the development of F-18-containing nonpeptide PLT radioligands for CRHR1. Published by Elsevier Science Ltd.
引用
收藏
页码:707 / 710
页数:4
相关论文
共 19 条
[1]   Non-peptide corticotropin-releasing hormone antagonists: Syntheses and structure-activity relationships of 2-anilinopyrimidines and -triazines [J].
Arvanitis, AG ;
Gilligan, PJ ;
Chorvat, RJ ;
Cheeseman, RS ;
Christos, TE ;
Bakthavatchalam, R ;
Beck, JP ;
Cocuzza, AJ ;
Hobbs, FW ;
Wilde, RG ;
Arnold, C ;
Chidester, D ;
Curry, M ;
He, LQ ;
Hollis, A ;
Klaczkiewicz, J ;
Krenitsky, PJ ;
Rescinito, JP ;
Scholfield, E ;
Culp, S ;
De Souza, EB ;
Fitzgerald, L ;
Grigoriadis, D ;
Tam, SW ;
Wong, YN ;
Huang, SM ;
Shen, HL .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (05) :805-818
[2]   The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist [J].
Baram, TZ ;
Chalmers, DT ;
Chen, C ;
Koutsoukos, Y ;
DeSouza, EB .
BRAIN RESEARCH, 1997, 770 (1-2) :89-95
[3]  
Bremner JD, 1997, AM J PSYCHIAT, V154, P624
[4]  
Chen C, 1996, J MED CHEM, V39, P4358
[5]   Synthesis and oral efficacy of a 4-(butylethylamino)pyrrolo[2,3-d]pyrimidine: A centrally active corticotropin-releasing factor(1) receptor antagonist [J].
Chen, YL ;
Mansbach, RS ;
Winter, SM ;
Brooks, E ;
Collins, J ;
Corman, ML ;
Dunaiskis, AR ;
Faraci, WS ;
Gallaschun, RJ ;
Schmidt, A ;
Schulz, DW .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (11) :1749-1754
[6]  
CHEN YL, Patent No. 9413676
[7]   Synthesis, corticotropin-releasing factor receptor binding affinity, and pharmacokinetic properties of triazolo-, imidazo-, and pyrrolopyrimidines and -pyridines [J].
Chorvat, RJ ;
Bakthavatchalam, R ;
Beck, JP ;
Gilligan, PJ ;
Wilde, RG ;
Cocuzza, AJ ;
Hobbs, FW ;
Cheeseman, RS ;
Curry, M ;
Rescinito, JP ;
Krenitsky, P ;
Chidester, D ;
Yarem, JA ;
Klaczkiewicz, JD ;
Hodge, CN ;
Aldrich, PE ;
Wasserman, ZR ;
Fernandez, CH ;
Zaczek, R ;
Fitzgerald, LW ;
Huang, SM ;
Shen, HL ;
Wong, YN ;
Chien, BM ;
Quon, CY ;
Arvanitis, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (05) :833-848
[8]   SEMINARS IN MEDICINE OF THE BETH-ISRAEL-HOSPITAL, BOSTON - THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS AND IMMUNE-MEDIATED INFLAMMATION [J].
CHROUSOS, GP .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (20) :1351-1362
[9]   The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress [J].
Deak, T ;
Nguyen, KT ;
Ehrlich, AL ;
Watkins, LR ;
Spencer, RL ;
Maier, SF ;
Licinio, J ;
Wong, ML ;
Chrousos, GP ;
Webster, E ;
Gold, PW .
ENDOCRINOLOGY, 1999, 140 (01) :79-86
[10]  
Griebel G, 1998, PSYCHOPHARMACOLOGY, V138, P55